{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:45:18Z","timestamp":1790210718326,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019973","name":"Luxembourg Government Ministry of Higher Education and Research","doi-asserted-by":"publisher","award":["LIH GBB 98000005"],"award-info":[{"award-number":["LIH GBB 98000005"]}],"id":[{"id":"10.13039\/501100019973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"publisher","award":["C22\/BM\/17380893\/PSEUDO"],"award-info":[{"award-number":["C22\/BM\/17380893\/PSEUDO"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21145"],"award-info":[{"award-number":["CA21145"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007526","name":"Universit\u00e9 de Tours","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ebiom.2025.105926","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T01:40:42Z","timestamp":1758073242000},"page":"105926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-019X","authenticated-orcid":false,"given":"Aubin","family":"Pitiot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Brandus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Iserentant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-0278","authenticated-orcid":false,"given":"Camille","family":"Rolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Fouquenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9la\u00efde","family":"Chesnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Briard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Si-Tahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Mely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Rassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Desoubeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Dervillez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Seguin-Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/cells12010199","article-title":"Pseudomonas aeruginosa: infections, animal modeling, and therapeutics","volume":"12","author":"Wood","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105926_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105926_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/vaccines10111789","article-title":"Antibody-based immunotherapies as a tool for tackling multidrug-resistant bacterial infections","volume":"10","author":"Seixas","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105926_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105926_bib7","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.cmi.2018.08.004","article-title":"Phase 1 study of MEDI3902, an investigational anti\u2013Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults","volume":"25","author":"Ali","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13054-022-04204-9","article-title":"Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial","volume":"26","author":"Chastre","year":"2022","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105926_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350814","article-title":"The complement system: a key player in the host response to infections","volume":"54","author":"Jayaraman","year":"2024","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105926_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI109138","article-title":"The effect of complement depletion on lung clearance of bacteria","volume":"62","author":"Gross","year":"1978","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1128\/iai.52.3.853-857.1986","article-title":"Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds","volume":"52","author":"Cerquetti","year":"1986","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105926_bib12","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1128\/IAI.72.5.2899-2906.2004","article-title":"The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia","volume":"72","author":"Mueller-Ortiz","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105926_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008893","article-title":"Bacterial behavior in human blood reveals complement evaders with some persister-like features","volume":"16","author":"Pont","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2025.105926_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1328185","article-title":"Factor H-related protein 1 promotes complement-mediated opsonization of Pseudomonas aeruginosa","volume":"14","author":"Gonz\u00e1lez-Alsina","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ebiom.2025.105926_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I: molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105926_bib16","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases","volume":"34","author":"Bajic","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/j.ebiom.2025.105926_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/microorganisms11030664","article-title":"Pseudomonas aeruginosa and the complement system: a review of the evasion strategies","volume":"11","author":"Gonz\u00e1lez-Alsina","year":"2023","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105926_bib19","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.3390\/ijms24044030","article-title":"Polysaccharides' structures and functions in biofilm architecture of antimicrobial-resistant (AMR) pathogens","volume":"24","author":"Balducci","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105926_bib20","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.3390\/ijms24108709","article-title":"How three self-secreted biofilm exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and alginate, can each be exploited for antibiotic adjuvant effects in cystic fibrosis lung infection","volume":"24","author":"Chung","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1462-5822.2011.01704.x","article-title":"Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization","volume":"14","author":"Mishra","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.ebiom.2025.105926_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.816356","article-title":"Molecular analysis of the contribution of alkaline protease A and elastase B to the virulence of Pseudomonas aeruginosa bloodstream infections","volume":"11","author":"Mateu-Borr\u00e1s","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4049\/jimmunol.1102162","article-title":"Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways","volume":"188","author":"Laarman","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2025.105926_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01675","article-title":"Pseudomonas aeruginosa LasB subverts alveolar macrophage activity by interfering with bacterial killing through downregulation of innate immune defense, reactive oxygen species generation, and complement activation","volume":"9","author":"Bastaert","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105926_bib25","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1084\/jem.20132444","article-title":"Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing","volume":"211","author":"Wells","year":"2014","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105926_bib26","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.4049\/jimmunol.179.5.2979","article-title":"Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein","volume":"179","author":"Kunert","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2025.105926_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02351","article-title":"The diverse functional roles of elongation factor Tu (EF-Tu) in microbial pathogenesis","volume":"10","author":"Harvey","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2025.105926_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101341","article-title":"Regulation of regulators: role of the complement factor H-related proteins","volume":"45","author":"Cserhalmi","year":"2019","journal-title":"Semin Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105926_bib29","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.4049\/jimmunol.1800662","article-title":"Cutting edge: FHR-1 binding impairs factor H\u2013mediated complement evasion by the malaria parasite Plasmodium falciparum","volume":"201","author":"Reiss","year":"2018","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105926_bib30","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.4049\/jimmunol.1200386","article-title":"Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen","volume":"189","author":"Hallstr\u00f6m","year":"2012","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105926_bib31","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/1878-0261.12554","article-title":"FHR4-based immunoconjugates direct complement-dependent cytotoxicity and phagocytosis towards HER2-positive cancer cells","volume":"13","author":"Seguin-Devaux","year":"2019","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04669-4","article-title":"Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure","volume":"21","author":"Schober","year":"2023","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4049\/jimmunol.2100378","article-title":"Differential enhancement of neutrophil phagocytosis by anti-bactericidal\/permeability-increasing protein antibodies","volume":"207","author":"Theprungsirikul","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2025.105926_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635825","article-title":"Use of flow cytometry to evaluate phagocytosis of Staphylococcus aureus by human neutrophils","volume":"12","author":"Boero","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105926_bib35","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ebiom.2025.105926_bib36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fmicb.2019.00600","article-title":"Targeting Aspergillus fumigatus Crf transglycosylases with neutralizing antibody is relevant but not sufficient to erase fungal burden in a neutropenic rat model","volume":"10","author":"Chauvin","year":"2019","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105926_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00055-25","article-title":"Strain-specific variation in the complement resistome of Pseudomonas aeruginosa","volume":"93","author":"Janet-Maitre","year":"2025","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105926_bib39","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.4049\/jimmunol.181.7.4945","article-title":"Neutrophil elastase mediates innate host protection against Pseudomonas aeruginosa","volume":"181","author":"Hirche","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2025.105926_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/JIR.S284941","article-title":"Studying neutrophil function in vitro: cell models and environmental factors","volume":"14","author":"Blanter","year":"2021","journal-title":"J Inflamm Res"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105926_bib41","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1128\/AAC.01841-09","article-title":"Microbial growth inhibition by alternating electric fields in mice with Pseudomonas aeruginosa lung infection","volume":"54","author":"Giladi","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2025.105926_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.ai.2015.09.001","article-title":"Mechanism of diapedesis: importance of the transcellular route","volume":"129","author":"Filippi","year":"2016","journal-title":"Adv Immunol"},{"issue":"10459","key":"10.1016\/j.ebiom.2025.105926_bib43","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105926_bib44","series-title":"Current Topics in Microbiology and Immunology","doi-asserted-by":"crossref","DOI":"10.1007\/82_2024_265","article-title":"Monoclonal antibody therapies for infectious diseases","author":"Casadevall","year":"2024"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105926_bib45","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105926_bib46","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/ijc.23238","article-title":"The possible role of factor H in colon cancer resistance to complement attack","volume":"122","author":"Wilczek","year":"2008","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105926_bib47","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jmb.2012.12.017","article-title":"Arranged sevenfold: structural insights into the C-terminal oligomerization domain of human C4b-binding protein","volume":"425","author":"Hofmeyer","year":"2013","journal-title":"J Mol Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105926_bib48","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/cmdc.200900023","article-title":"Multimerization of peptide mimotopes for blocking of factor VIII neutralizing antibodies","volume":"4","author":"Kessel","year":"2009","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105926_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0753-3322(00)88106-8","article-title":"In-vivo delivery of therapeutic proteins by genetically-modified cells: comparison of organoids and human serum albumin alginate-coated beads","volume":"53","author":"Shinya","year":"1999","journal-title":"Biomed Pharmacother"},{"issue":"49","key":"10.1016\/j.ebiom.2025.105926_bib50","doi-asserted-by":"crossref","first-page":"38473","DOI":"10.1074\/jbc.M110.143727","article-title":"Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels","volume":"285","author":"Reuter","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2025.105926_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01297","article-title":"Interaction of the factor H family proteins FHR-1 and FHR-5 with DNA and dead cells: implications for the regulation of complement activation and opsonization","volume":"11","author":"K\u00e1rp\u00e1ti","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib52","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/QCO.0000000000000539","article-title":"Monoclonal antibody-based therapies for bacterial infections","volume":"32","author":"Motley","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105926_bib53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2017.12.006","article-title":"KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa","volume":"17","author":"Jain","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105926_bib54","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/CCM.0b013e31825334f6","article-title":"Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized, double-blind, placebo-controlled trial","volume":"40","author":"Fran\u00e7ois","year":"2012","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/cc13697","article-title":"Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes","volume":"18","author":"Lu","year":"2014","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00864-17","article-title":"Psl produced by mucoid Pseudomonas aeruginosa contributes to the establishment of biofilms and immune evasion","volume":"8","author":"Jones","year":"2017","journal-title":"mBio"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105926_bib57","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20120033","article-title":"Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening","volume":"209","author":"Digiandomenico","year":"2012","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105926_bib58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/514050","article-title":"Neutralization of cytomegalovirus virions: the role of complement","volume":"176","author":"Spiller","year":"1997","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105926_bib59","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.1000284","article-title":"Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody","volume":"186","author":"Siggins","year":"2011","journal-title":"J Immunol"},{"issue":"4\u20135","key":"10.1016\/j.ebiom.2025.105926_bib60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002620000120","article-title":"Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors","volume":"49","author":"Bergman","year":"2000","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48461-1","article-title":"A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells","volume":"9","author":"Cruz","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib62","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1038\/s41598-018-25714-z","article-title":"Synergistic combination of two antimicrobial agents closing each other's mutant selection windows to prevent antimicrobial resistance","volume":"8","author":"Xu","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105926_bib63","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ja.2017.102","article-title":"Suppressive drug combinations and their potential to combat antibiotic resistance","volume":"70","author":"Singh","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105926_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0757.2010.00373.x","article-title":"Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity","volume":"54","author":"McCormick","year":"2010","journal-title":"Periodontol 2000"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41598-022-27279-4","article-title":"Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1","volume":"13","author":"Boero","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105926_bib67","first-page":"460","article-title":"Regulation of human neutrophil type 3 complement receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli","volume":"67","author":"Gordon","year":"1989","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12952-017-0067-2","article-title":"Antimicrobial activity of HL-60 cells compared to primary blood-derived neutrophils against Staphylococcus aureus","volume":"16","author":"Yaseen","year":"2017","journal-title":"J Negat Results Biomed"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105926_bib69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.yrtph.2012.03.010","article-title":"Strategies for the optimisation of in vivo experiments in accordance with the 3Rs philosophy","volume":"63","author":"Madden","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105926_bib70","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/IAI.68.7.4289-4296.2000","article-title":"CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia","volume":"68","author":"Tsai","year":"2000","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105926_bib71","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1074\/jbc.M406968200","article-title":"Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2","volume":"280","author":"Solovjov","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2025.105926_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.597595","article-title":"Lung marginated and splenic murine resident neutrophils constitute pioneers in tissue-defense during systemic E. coli challenge","volume":"12","author":"Juzenaite","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105926_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064443","article-title":"Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury","volume":"8","author":"Garcia","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105926_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.274","article-title":"Complement C5a exacerbates acute lung injury induced through autophagy-mediated alveolar macrophage apoptosis","volume":"5","author":"Hu","year":"2014","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105926_bib75","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.201910-2083OC","article-title":"Increased alternative complement pathway function and improved survival during critical illness","volume":"202","author":"Bain","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105926_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrmicro2536","article-title":"Shifting the balance: antibiotic effects on host-microbiota mutualism","volume":"9","author":"Willing","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105926_bib77","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1462-2920.2011.02657.x","article-title":"The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix","volume":"14","author":"Colvin","year":"2012","journal-title":"Environ Microbiol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105926_bib78","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1086\/528992","article-title":"Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing","volume":"197","author":"Kristian","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105926_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108022","article-title":"Therapeutic antibodies - natural and pathological barriers and strategies to overcome them","volume":"233","author":"Al Ojaimi","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105926_bib80","article-title":"Antibiotic prophylaxis in surgery: current insights and future directions for surgical site infection prevention","volume":"15","author":"Dhole","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105926_bib81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.it.2020.12.002","article-title":"Complement factors in COVID-19 therapeutics and vaccines","volume":"42","author":"Kurtovic","year":"2021","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105926_bib82","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib83","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105926_bib84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2471\/BLT.16.178061","article-title":"Therapeutic antibodies for infectious diseases","volume":"95","author":"Sparrow","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ebiom.2025.105926_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108233","article-title":"Monoclonal antibody therapeutics for infectious diseases: beyond normal human immunoglobulin","volume":"240","author":"Otsubo","year":"2022","journal-title":"Pharmacol Ther"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:39:17Z","timestamp":1772905157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425003706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":85,"alternative-id":["S2352396425003706"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105926","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105926"}}